Biosimilar Newsletter Archive

  1. 03.16.23 -- Sandoz To Build New Biologics Plant In Slovenia 3/16/2023
    03/16/23 Biosimilar Development Newsletter
  2. 03.09.23 -- Protect Your Drug By Setting High Standards For Your Packaging 3/9/2023

    03/09/23 Biosimilar Development Newsletter

  3. 03.09.23 -- FDA, FTC Collaborate To Advance Biologics Competition 3/9/2023
    03/09/23 Biosimilar Development Newsletter
  4. 03.06.23 -- Resources To Help You Assess Your Current Level Of Digital Automation 3/6/2023

    03/06/23 Biosimilar Development Newsletter

  5. 03.02.23 -- 6 Strategies To Protect Your Biologics Supply Chain In 2023 3/2/2023
    03/02/23 Biosimilar Development Newsletter
  6. 03.01.23 -- 6 Risk-Mitigating Solutions For Your Biologic's Development 3/1/2023

    03/01/23 Biosimilar Development Newsletter

  7. 02.23.23 -- EMA's Revised GMP Annex 1 Addresses Common Global Challenges For Sterile Products 2/23/2023
    02/23/23 Biosimilar Development Newsletter
  8. 02.21.23 -- Improve Your Productivity With The Use Of Effective Modular Systems 2/21/2023

    02/21/23 Biosimilar Development Newsletter

  9. 02.16.23 -- FDA Adopts ICH Final Guidance On Bioanalytical Method Validation 2/16/2023
    02/16/23 Biosimilar Development Newsletter
  10. 02.09.23 -- First Humira Biosimilar Now Available In U.S. 2/9/2023
    02/09/23 Biosimilar Development Newsletter